19 June 2013
Keywords: final, fda, approval, ranbaxy, amlodipine, pharmaceuticals, subsidiary
Article | 16 July 2007
Ranbaxy Pharmaceuticals, the US subsidiary of India's Ranbaxy group, has received final approval from the Food and Drug Administration to
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 July 2007
9 July 2007
18 June 2013
© 2013 thepharmaletter.com